stockportfolio.pro
DexCom, Inc. P/E Ratio 2009–2025
DexCom, Inc. (DXCM) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -10.8%/yr over 16 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 31.76 | -42.0% |
| FY 2024 | 54.77 | -42.6% |
| FY 2023 | 95.45 | -30.9% |
| FY 2022 | 138.10 | -45.5% |
| FY 2021 | 253.28 | +264.4% |
| FY 2020 | 69.50 | -65.1% |
| FY 2019 | 198.85 | — |
| FY 2018 | — | — |
| FY 2017 | — | — |
| FY 2016 | — | — |
| FY 2015 | — | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
| FY 2012 | — | — |
| FY 2011 | — | — |
| FY 2010 | — | — |
| FY 2009 | — | — |
Source: DexCom, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for DexCom, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeDexCom, Inc. — frequently asked questions
What is DexCom, Inc.'s price-to-earnings ratio?
DexCom, Inc. (DXCM) reported price-to-earnings ratio of 31.76 for fiscal year 2025, per its SEC filings.
How has DexCom, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2009 and 2025, DXCM's price-to-earnings ratio declined at roughly 10.8% per year (compound annual rate), from 198.85 to 31.76.
Where does this data come from?
Figures are computed from DexCom, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.